Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.10.5843

HPV Genotyping Linear Assay Test Comparison in Cervical Cancer Patients: Implications for HPV Prevalence and Molecular Epidemiology in a Limited-resource Area in Bandung, Indonesia  

Panigoro, Ramdan (Department of Biochemistry, Hasan Sadikin Hospital)
Susanto, Herman (Department of Obstetrics and Gynecology, Hasan Sadikin Hospital)
Novel, Sinta Sasika (Health Research Unit, Faculty of Medicine Universitas Padjadjaran)
Hartini, Sri (Lab of Clinical Pathology, Dharmais National Cancer Hospital)
Sahiratmadja, Edhyana (Department of Biochemistry, Hasan Sadikin Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.10, 2013 , pp. 5843-5847 More about this Journal
Abstract
Background: Persistent infection with high risk human papillomavirus (hrHPV) is strongly associated with cervical cancer. Normal cervical cells may also harbor hrHPV, and detection of early hrHPV infection may minimize risk of cervical cancer development. This study aimed to compare two commercial HPV genotyping assays that may affordable for early screening in a limited-resource setting in Bandung, Indonesia. Materials and Methods: DNA from cervical biopsies with histologically confirmed as squamous cell cervical cacinoma were HPV genotyped by Linear Assay 1 (Roche Diagnostics, Mannheim, Germany) or Linear Assay 2 (Digene HPV Genotyping RH Test, Qiagen Gaithersburg, MD). In a subset of samples of each group, HPV genotype results were then compared. Results: Of 28 samples genotyped by linear assay 1, 22 (78.6%) demonstrated multiple infections with HPV-16 and other hrHPV types 18, 45 and/or 52. In another set of 38 samples genotyped by linear assay 2, 28 (68.4%) were mostly single infections by hrHPV type 16 or 18. Interestingly, 4 samples that had been tested by both kits showed discordant results. Conclusions: In a limited-resource area such as in Indonesia, country with a high prevalence of HPV infection a reliable cervical screening test in general population for early hrHPV detection is needed. Geographical variation in HPV genotyping result might have impacts for HPV prevalence and molecular epidemiology as the distribution in HPV genotypes should give clear information to assess the impact of HPV prophylactic vaccines.
Keywords
Cervical cancer; HPV genotypes; linear assay; Bandung Indonesia;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 de Sanjose S, Quint WG, Alemany L, et al (2010). Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol, 11, 1048-56.   DOI   ScienceOn
2 Aziz MF (2009). Gynecological cancer in Indonesia. J Gynecol Oncol, 20, 8-10.   DOI   ScienceOn
3 Bradford L, Goodman A (2013). Cervical cancer screening and prevention in low-resource settings. Clin Obstet Gynecol, 56, 76-87.   DOI
4 Bruni L, Diaz M, Castellsague X, et al (2010). Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis, 202, 1789-99.   DOI   ScienceOn
5 Castellsague X (2008). Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol, 110, 4-7.   DOI   ScienceOn
6 de Sanjose S, Diaz M, Castellsague X, et al. (2007). Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 7, 453-9.   DOI   ScienceOn
7 Domingo EJ, Noviani R, Noor MR, et al (2008). Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam. Vaccine, 26, 71-9.   DOI   ScienceOn
8 Dona MG, Benevolo M, Pimpinelli F, et al (2011). Comparative evaluation of different DNA extraction methods for HPV genotyping by linear array and INNO-LiPA. J Med Virol, 83, 1042-7.   DOI   ScienceOn
9 Ge S, Gong B, Cai X, et al (2012). Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping. Cancer Med, 1, 59-67.   DOI
10 Hoppenot C, Stampler K, Dunton C (2012). Cervical cancer screening in high- and low-resource countries: implications and new developments. Obstet Gynecol Surv, 67, 658-67.   DOI   ScienceOn
11 Lindemann ML, Dominguez MJ, de Antonio JC, et al (2012). Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn, 14, 65-70.   DOI   ScienceOn
12 Martinez SB, Palomares JC, Artura A, et al (2012). Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples. J Virol Methods, 180, 7-10.   DOI   ScienceOn
13 Rachmadi L, Jordanova ES, Kolkman-Uljee S, et al (2012). Cytomorphological analysis of uterine cervical pap smears in relation to human papillomavirus infection in Indonesian women. Acta Cytol, 56, 171-6.   DOI   ScienceOn
14 Munoz N, Bosch FX, de Sanjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27.   DOI   ScienceOn
15 Nandini NM, Nandish SM, Pallavi P, et al (2012). Manual liquid based cytology in primary screening for cervical cancer - a cost effective preposition for scarce resource settings. Asian Pac J Cancer Prev, 13, 3645-51.   과학기술학회마을   DOI   ScienceOn
16 Pannone G, Rodolico V, Santoro A, et al (2012). Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization. Infect Agent Cancer, 7, 4.   DOI   ScienceOn
17 Steinau M, Onyekwuluje JM, Scarbrough MZ, et al (2012). Performance of Commercial Reverse Line Blot Assays for HPV Genotyping. J Clin Microbiol, 50, 1539-44.   DOI
18 Schellekens MC, Dijkman A, Aziz MF, et al (2004). Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol, 93, 49-53.   DOI   ScienceOn
19 Smith JS, Lewkowitz AK, Qiao YL, et al (2012)Population-based human papillomavirus 16, 18, 6 and 11 DNA positivity and seropositivity in Chinese women. Int J Cancer, 131, 1388-95.   DOI   ScienceOn
20 Song SH, Hong JH, Kwak SH, et al (2012). Clinical performance assessment of five human papillomavirus DNA tests using liquid-based cytology samples. J Obstet Gynaecol Res, 38, 408-14.   DOI   ScienceOn
21 Vet JN, de Boer MA, van den Akker BE, et al (2008). Prevalence of human papillomavirus in Indonesia: a population-based study in three regions. Br J Cancer, 99, 214-8.   DOI   ScienceOn
22 Wong OG, Lo CK, Chow JN, et al (2012). Comparison of GenoFlow HPV test and Linear Array in an Asian Screening Population. J Clin Microbiol, 50, 1691-7.   DOI
23 Wong FKY, Ching JCY, Chow JKF (2010). Comparison of the DiagCor GenoFlow Human Papillomavirus Array Test and Roche Linear Array HPV Genotyping Test. Open Virol J, 4, 169-74.